These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38809626)
1. Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor. Hasanlu M; Amiri-Dashatan N; Farahani M; Koushki M; Ahmadi H; Parsamanesh N; Ahmadi NA Asian Pac J Cancer Prev; 2024 May; 25(5):1547-1558. PubMed ID: 38809626 [TBL] [Abstract][Full Text] [Related]
2. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer. Li D; Zhao W; Zhang X; Lv H; Li C; Sun L Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer. Xu L; Peng H; Huang XX; Xia YB; Hu KF; Zhang ZM Braz J Med Biol Res; 2018 Jul; 51(9):e7588. PubMed ID: 30043858 [TBL] [Abstract][Full Text] [Related]
4. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma. Ling J; Peng N; Luo L J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393 [TBL] [Abstract][Full Text] [Related]
5. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7. Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742 [TBL] [Abstract][Full Text] [Related]
6. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer. Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062 [TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer. Han B; Zhen F; Zheng XS; Hu J; Chen XS BMC Cancer; 2022 Mar; 22(1):297. PubMed ID: 35313846 [TBL] [Abstract][Full Text] [Related]
8. Genetic and expressional alterations of CHD genes in gastric and colorectal cancers. Kim MS; Chung NG; Kang MR; Yoo NJ; Lee SH Histopathology; 2011 Apr; 58(5):660-8. PubMed ID: 21447119 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the expression, prognosis, and immune infiltrates for CHDs in human lung cancer. Lv Y; Lin W Discov Oncol; 2022 Apr; 13(1):29. PubMed ID: 35467222 [TBL] [Abstract][Full Text] [Related]
11. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer. Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268 [TBL] [Abstract][Full Text] [Related]
12. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer. Shi W; Xu C; Lei P; Sun X; Song M; Guo Y; Song W; Li Y; Yu L; Zhang H; Wang H; Zhang DL Breast Cancer Res Treat; 2024 Sep; 207(2):417-434. PubMed ID: 38834774 [TBL] [Abstract][Full Text] [Related]
13. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer. Lin T; Qiu Y; Peng W; Peng L Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341 [TBL] [Abstract][Full Text] [Related]
14. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer. Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413 [TBL] [Abstract][Full Text] [Related]
15. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer. Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161 [TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics and oncogenic role of CHD family genes: a pan-cancer analysis based on bioinformatic and biological analysis. Lu Y; Jiang J; He Z; Bao Z; Chen X; Cheng J Sci Rep; 2024 Aug; 14(1):18923. PubMed ID: 39143142 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers. Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825 [TBL] [Abstract][Full Text] [Related]
18. Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis. Yang Y; Li F; Luo X; Jia B; Zhao X; Liu B; Gao R; Yang L; Wei W; He J DNA Cell Biol; 2019 Oct; 38(10):1088-1099. PubMed ID: 31424267 [TBL] [Abstract][Full Text] [Related]
19. PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer. Guo J; Du X; Li C Biomed Res Int; 2022; 2022():4434887. PubMed ID: 35535040 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer. Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]